CRI Lifetree appoints Craig-Rodriguez and Marcos to leadership team

Friday, September 28, 2012 02:59 PM

CRI Lifetree, a multi-therapeutic early stage research company, has strengthened its early phase leadership with the appointments of Alicia Craig-Rodriguez as chief operating officer and Jose Marcos as East Coast director of clinical operations. 

Craig-Rodriguez has more than 25 years of leadership experience, including 15 years of overseeing the operational, regulatory and quality compliance of more than 1,000 clinical trials. She has led teams in the creation of comprehensive and industry-compliant SOPs, quality management programs and employee training. Prior to joining CRI Lifetree, Craig-Rodriguez served as president of Comprehensive Clinical Development.

Marcos will add 18 years of experience in hands-on phase I expertise to CRI Lifetree’s leadership team. Prior to joining CRI Lifetree, Marcos served as vice president of phase I clinical operations at Comprehensive Clinical Development. During his tenure there, Marcos advanced the operating infrastructure from a single, 36-bed unit to include three state-of-the-art facilities with a bed capacity exceeding 400 beds.

Share:          
CWWeekly

July 27

AB Science warned about putting study volunteers in danger

FDA, Google unite to detect search-data adverse events

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs